申请人:Pfizer Inc.
公开号:US20030162795A1
公开(公告)日:2003-08-28
The invention relates to compounds of the formulas 1 and 2
1
and to pharmaceutically acceptable salts and hydrates thereof, wherein X
1
, R
1
, R
2
and R
11
are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formulas 1 and 2 and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formulas 1 and 2.
本发明涉及公式1和21的化合物,以及其药学上可接受的盐和水合物,其中X1、R1、R2和R11如本文所定义。本发明还涉及含有公式1和2化合物的制药组合物,以及通过给哺乳动物注射公式1和2化合物来治疗增殖过度性疾病的方法。